About Candesant
Candesant is a company based in San Francisco (United States) founded in 2016 by Niquette Hunt. Candesant has raised $44.49 million across 2 funding rounds from investors including KCK MedTech, Polaris Partners and Astia. The company has 3 employees as of December 31, 2021. Candesant operates in a competitive market with competitors including Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
- Headquarter San Francisco, United States
- Employees 3 as on 31 Dec, 2021
- Founders Niquette Hunt
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Candesant Biomedical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.49 M (USD)
in 2 rounds
-
Latest Funding Round
$35.36 M (USD), Series B
Jun 06, 2023
-
Investors
KCK MedTech
& 3 more
-
Employee Count
3
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Candesant
Unlock access to complete
Funding Insights of Candesant
Candesant has successfully raised a total of $44.49M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $35.36 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $35.4M
-
First Round
First Round
(14 Feb 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series B - Candesant | Valuation | KCK MedTech | |
| Feb, 2020 | Amount | Series A - Candesant | Valuation |
investors |
|
Investors in Candesant
Candesant has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include KCK MedTech, Polaris Partners and Astia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Women-led startups are funded through stage-agnostic investments and angel networks.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Candesant
Financial Statements - Candesant
Candesant Comparisons
Competitors of Candesant
Candesant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops topical microparticle therapies for dermatological conditions.
|
|
| domain | founded_year | HQ Location |
Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections
|
|
| domain | founded_year | HQ Location |
Offers coal tar and light combination therapy for effective psoriasis treatment.
|
|
| domain | founded_year | HQ Location |
Nanoparticle-based products for cosmetics and health sectors are developed.
|
|
| domain | founded_year | HQ Location |
Sells devices for fat reduction, body shaping, and skin firming online.
|
Latest news on Candesant
Frequently Asked Questions about Candesant
Candesant was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Candesant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Niquette Hunt is the current CEO of Candesant. They have also founded this company.
Candesant is a funded company, having raised a total of $44.49M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.13M, raised on Feb 14, 2020.
As of Dec 31, 2021, the latest employee count at Candesant is 3.
Candesant Biomedical was founded in 2016 in San Francisco, United States, and operates in the biomedical sector. A proprietary non-invasive device, CDX-101, is offered for treating hyperhidrosis by targeting and inactivating overactive sweat glands. The device is applied under the arms like a patch, where alkali metals interact with water to generate energy that reduces sweating and inhibits bacterial growth.
Candesant's top competitors include PhotoSonix Medical, Nano Ceuticals and Sebacia.
Candesant has 4 investors. Key investors include KCK MedTech, Polaris Partners, Astia, and Correlation Ventures.